Clinical studies have shown that reduced glutathione concentration and/or a disproportionate ratio of GSH:GSSG [glutathione to oxidized glutathione] has been associated with a number of diseases, including cancer, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), hepatitis, type 2 diabetes, Parkinsons disease, and cystic fibrosis (Allen & Bradley, 2011)
We start treatment at a lower dose and gradually increase it over several weeks to reduce the risk of gastrointestinal side effects, which are the most common with semaglutide GLP-1
Kakei, M., Yada, T., Nakagawa, A
Heart disease can happen to anyone, including children
However, the timeline for significant results varies depending on whether your goal is weight loss or blood sugar control, with full benefits developing over several months of consistent use